Edition:
India

People: China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

5.35HKD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
HK$5.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,293,680
52-wk High
HK$5.45
52-wk Low
HK$1.57

Lo, Kai 

Mr. Lo Kai (Lawrence) is Independent Non-Executive Director of China Grand Pharmaceutical and Healthcare Holdings Ltd. Mr. Lo was appointed independent non-executive director of the Company in June 2008. Mr Lo has over 25 years of experience in wealth and asset management business. Currently, he is the CEO of UBP Asia Limited. Prior to that, he was the CEO of BSI-Generali Asia (“BSI”) and was responsible for wealth management and asset management activities in Asia. Prior to BSI, he was the CEO of BNP Paribas Asset Management Asia, Head of Asset Management and Private Banking Asia for Banque Paribas from 1993 to 2000. Mr Lo holds a Master of Science degree in Economics at London School of Economics and Political Science.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Chengwei Liu

50,000

Yan Shao

1,516,000

Bo Hu

50,000

Zhanqi Niu

--

Yonghua Feng

--

Xiaofeng Shi

--
As Of  31 Dec 2014